Business Description
Medicamen Organics Ltd
ISIN : INE0PE401018
Total Employee Number:
114Compare
Compare
Traded in other countries / regions
MEDIORG.India IPO Date
2024-06-28Description
Medicamen Organics Ltd develops, manufactures, and distributes a wide range of pharmaceutical dosage forms, including Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders. The company operates two WHO Good Manufacturing Practice certified facilities in India, producing products for both domestic and international clients. It provides contract manufacturing and loan license services to various pharmaceutical companies and exports to several countries across Africa, CIS, and South Asia. The principal source of revenue is through the manufacturing, export, and contract services focused on generic and branded pharmaceutical formulations.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.5 | |||||
Debt-to-EBITDA | -2 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 1.2 | |||||
Beneish M-Score | -1.32 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.5 | |||||
3-Year FCF Growth Rate | -93.1 | |||||
3-Year Book Growth Rate | 47 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 71.03 | |||||
9-Day RSI | 59.06 | |||||
14-Day RSI | 54.34 | |||||
3-1 Month Momentum % | -22.37 | |||||
6-1 Month Momentum % | 6.51 | |||||
12-1 Month Momentum % | -41.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.69 | |||||
Quick Ratio | 1.21 | |||||
Cash Ratio | 0.06 | |||||
Days Inventory | 439.42 | |||||
Days Sales Outstanding | 1698.82 | |||||
Days Payable | 421.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | -6.18 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -56.52 | |||||
Operating Margin % | -160.37 | |||||
Net Margin % | -126.78 | |||||
EBITDA Margin % | -149.79 | |||||
FCF Margin % | -132.56 | |||||
OCF Margin % | -96.18 | |||||
ROE % | -20.58 | |||||
ROA % | -10.93 | |||||
ROIC % | -13.21 | |||||
3-Year ROIIC % | -21.44 | |||||
ROC (Joel Greenblatt) % | -21.16 | |||||
ROCE % | -24.68 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 5.91 | |||||
PB Ratio | 0.99 | |||||
Price-to-Tangible-Book | 1 | |||||
EV-to-EBIT | -5.36 | |||||
EV-to-EBITDA | -5.72 | |||||
EV-to-Revenue | 8.57 | |||||
EV-to-FCF | -6.26 | |||||
| Price-to-Net-Current-Asset-Value | 2.02 | |||||
Earnings Yield (Greenblatt) % | -18.66 | |||||
FCF Yield % | -22.56 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medicamen Organics Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 47.78 | ||
| EPS (TTM) (₹) | -5.15 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 56.75 | ||
| 14-Day RSI | 54.34 | ||
| 14-Day ATR (₹) | 0.658099 | ||
| 20-Day SMA (₹) | 23.7675 | ||
| 12-1 Month Momentum % | -41.73 | ||
| 52-Week Range (₹) | 19.1 - 45 | ||
| Shares Outstanding (Mil) | 11.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medicamen Organics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medicamen Organics Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medicamen Organics Ltd Frequently Asked Questions
What is Medicamen Organics Ltd(NSE:MEDIORG)'s stock price today?
The current price of NSE:MEDIORG is ₹24.00. The 52 week high of NSE:MEDIORG is ₹45.00 and 52 week low is ₹19.10.
When is next earnings date of Medicamen Organics Ltd(NSE:MEDIORG)?
The next earnings date of Medicamen Organics Ltd(NSE:MEDIORG) is .
Does Medicamen Organics Ltd(NSE:MEDIORG) pay dividends? If so, how much?
Medicamen Organics Ltd(NSE:MEDIORG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Medicamen Organics Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers